Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of AUX-001 in Healthy Subjects
NCT06249581Phase 1Active, not recruiting
- Sponsor
- Auxilius Pharma
- Start
- Nov 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of nicorandil in angina pectoris (2 arms), sponsored by Auxilius Pharma. Primary endpoints: Area under the curve over 24 hours of nicorandil, Maximum Plasma Concentration of nicorandil at 24 hours and 1 more. Started Nov 2023; status: active, not recruiting.
02
Drugs
nicorandil
03
Conditions
angina pectoris
Beyond the preview
Go deeper on NCT06249581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06249581.